LC-ESI-MS/MS identification and characterization of ponatinib in vivo phase I and phase II metabolites
Keywords: Ponatinib; Tyrosine kinase inhibitors; In vivo metabolites; Oxidized cyclic tertiary amine; Phase separation; Sprague Dawley rats;